Follow
CAR-T cell therapy
Chimeric antigen receptor (CAR) T cell therapy is a form of T cell engineering where T cells are obtained from a patient and engineered in a laboratory to better kill the patient's cancer cells. Specifically, CAR T cells are modified to express a receptor on their surface that recognizes the specific antigen present on the patient's cancer cells.
-
FEB 07, 2017Immunology
Mice models are more often than not the models of disease used to study the interaction between immune cells and cancer. ...Written By: Kara MarkerJAN 27, 2017Cell & Molecular Biology
Several years after receiving the treatment, scientists have confirmed that two infants with cancer that received a type ...Written By: Carmen LeitchAUG 01, 2016Immunology
A new treatment for the selective targeting of ovarian cancer cells has been adopted from chimeric antigen receptor (CAR ...Written By: Kara MarkerJUL 19, 2016Cancer
A decade-old technology to arm the immune system to fight cancer is now being adapted to fight HIV, one of the most pern ...JUN 27, 2016Immunology
T cells are the body’s natural fleet of cancer-attacking lymphocytes, but in recent years scientists have found a ...Written By: Kara MarkerFEB 18, 2016Health & Medicine
Dramatic remissions have been seen in a cancer immunotherapy trial for patients with blood cancers. Specifically, ...Written By: Julianne ChiaetNOV 02, 2015Immunology
B-cell leukemia occurs in 80-85 percent of children with acute lymphoblastic leukemia (ALL), a fast-growing cancer that ...Written By: Kara MarkerSEP 29, 2015Cancer
UC San Francisco scientists have developed a molecular “on switch” enabling tight control over the acti ...Written By: Ilene SchneiderSEP 13, 2015Cancer
A team at the University of Pennsylvania reported that a multiple myeloma patient whose cancer had stopped respondi ...Written By: Ilene SchneiderAPR 03, 2015Neuroscience
The war on PTSD, Gulf War Illness, and other illnesses suffered by veterans just got a boost from an unexpected source-l ...Written By: Will HectorFEB 27, 2015Genetics & Genomics
Genetically engineered T memory stem cells (Tscm) can last more than 12 years in patients' bodies, and can continually g ...Written By: Ilene SchneiderFEB 26, 2015Cancer
A study published in Science Translational Medicine showed that immune cells engineered to seek out and attack a type of ...Written By: Ilene Schneider
FEB 07, 2017
Immunology
Mice models are more often than not the models of disease used to study the interaction between immune cells and cancer.
...
Written By:
Kara Marker
JAN 27, 2017
Cell & Molecular Biology
Several years after receiving the treatment, scientists have confirmed that two infants with cancer that received a type
...
Written By:
Carmen Leitch
AUG 01, 2016
Immunology
A new treatment for the selective targeting of ovarian cancer cells has been adopted from chimeric antigen receptor (CAR
...
Written By:
Kara Marker
JUL 19, 2016
Cancer
A decade-old technology to arm the immune system to fight cancer is now being adapted to fight HIV, one of the most pern
...
JUN 27, 2016
Immunology
T cells are the body’s natural fleet of cancer-attacking lymphocytes, but in recent years scientists have found a
...
Written By:
Kara Marker
FEB 18, 2016
Health & Medicine
Dramatic remissions have been seen in a cancer immunotherapy trial for patients with blood cancers. Specifically,
...
Written By:
Julianne Chiaet
NOV 02, 2015
Immunology
B-cell leukemia occurs in 80-85 percent of children with acute lymphoblastic leukemia (ALL), a fast-growing cancer that
...
Written By:
Kara Marker
SEP 29, 2015
Cancer
UC San Francisco scientists have developed a molecular “on switch” enabling tight control over the acti
...
Written By:
Ilene Schneider
SEP 13, 2015
Cancer
A team at the University of Pennsylvania reported that a multiple myeloma patient whose cancer had stopped respondi
...
Written By:
Ilene Schneider
APR 03, 2015
Neuroscience
The war on PTSD, Gulf War Illness, and other illnesses suffered by veterans just got a boost from an unexpected source-l
...
Written By:
Will Hector
FEB 27, 2015
Genetics & Genomics
Genetically engineered T memory stem cells (Tscm) can last more than 12 years in patients' bodies, and can continually g
...
Written By:
Ilene Schneider
FEB 26, 2015
Cancer
A study published in Science Translational Medicine showed that immune cells engineered to seek out and attack a type of
...
Written By:
Ilene Schneider